DURECT CorpDRRX
Market Cap: $40.7M
About: Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
Employees: 58
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
149% more call options, than puts
Call options by funds: $269K | Put options by funds: $108K
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
27% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 11
15% more capital invested
Capital invested by funds: $8.4M [Q1] → $9.7M (+$1.3M) [Q2]
10% more funds holding
Funds holding: 41 [Q1] → 45 (+4) [Q2]
0.95% more ownership
Funds ownership: 23.29% [Q1] → 24.24% (+0.95%) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for DRRX.